Speakers – Dr Philip Blair MD, Chief Medical Officer, ICCM
Date and Time – 28th January | 8:30AM (AEDT)
This presentation will discuss the CB2R in detail including its location, function, induction and cascade of benevolent actions throughout the body. It will outline a broad range of systems regulation involving the immune, neurological, gastrointestinal and vascular responses. We will further discuss the induction of CB2R by diseases as well as by foods and herbs. Finally, we will talk about CB2 agonist from cannabis and non-cannabis sources and there particular benefit to the whole organism.